Incidence of Osteoporosis and the Risk of Fracture in Patients with Rheumatoid Arthritis Undergoing Corticosteroid Treatment
| Autor: | Mihaela Vladu, Otilia Constantina Rogoveanu, Anca Rosu, Veronica Calborean, Victor Gheorman, Tiberiu Stefanita Tenea Cojan, Lucretiu Radu, Cristina Gabriela Ene |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
business.industry Materials Science (miscellaneous) Process Chemistry and Technology Incidence (epidemiology) Osteoporosis General Engineering Corticosteroid treatment General Chemistry General Medicine 010402 general chemistry medicine.disease 01 natural sciences General Biochemistry Genetics and Molecular Biology 0104 chemical sciences Internal medicine Rheumatoid arthritis Materials Chemistry medicine In patient General Pharmacology Toxicology and Pharmaceutics business |
| Zdroj: | Revista de Chimie. 69:1851-1854 |
| ISSN: | 2668-8212 0034-7752 |
| Popis: | Rheumatoid arthritis (RA) is the most widespread inflammatory rheumatic disease with about 10% of all rheumatic diseases and a global prevalence of about 1%. Through its features - joint proliferation, articular panic, articular cartilage degradation and bone erosion � RA has a destructive and disabling character and a major socio-economic impact. Osteoporosis is a bone system disease characterized by loss of bone mass and alteration of bone architecture, with consequences on bone fragility correlated with an increased fracture risk. With a major socio-economic impact, the World Health Organization (WHO) has declared osteoporosis as a public health problem, third on cardiovascular and oncological. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|